Mila Ioussifova, OD, CNS, FAAO, FOWNS, details her AOA Optometry's Meeting 2026 session.
Mila Ioussifova, OD, FAAO
Advertisement
Articles by Mila Ioussifova, OD, FAAO
Mila Ioussifova, OD, CNS, FAAO, FOWNS, details her session on the hormonal and aesthetic considerations ODs should make when treating these patients.
AOA 2025: Innovation and education take forefront at Optometry's Meeting
ByClark Y. Chang, OD, MSA, MSc, FAAO,Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO,Mila Ioussifova, OD, FAAO,Jessilin Quint, OD, MBA, MS, FAAO,Nora Lee Cothran, OD, FAAO,Devin Sasser, OD,Doerte Luensmann, PhD, Dipl Ing (AO), FAAO,Jacob R. Lang, OD, FAAO,Carolyn Majcher, OD, FAAO,Jordana Joy, Editor
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
A few optometrists share which innovations in optometry they were most excited about in 2024.
Mila Ioussifova, OD, CNS, FAAO, FOWNS, tackled new and exciting ways to tackle meibomian gland dysfunction alongside fellow ocular surface specialist Rana Taji, OD, MSc, FAAO, at AAOpt 2024.
A rapid fire session details what's in the pipeline for ocular surface dryness therapies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
CLI study: Contact lens patients significantly more profitable than spectacle-only wearers
2
Detoxifying for visual longevity
3
Orasis Pharmaceuticals, BlinkRx partnership offers new dispensing options for Qlosi
4
Glaukos completes enrollment in pivotal trial of Preserflo MicroShunt for treatment-resistant glaucoma
5